Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Kidney Research and Clinical Practice|December 5, 2024
The importance of kidney response over hematologic response in predicting kidney outcome in amyloid light-chain amyloidosisSungmi Kim, Jinyoung Yang, Kyungho Lee, et al.
BMC Pulmonary Medicine|November 1, 2023
Lower socioeconomic status associated with higher tuberculosis rate in South KoreaSeong-Woo Choi, Jeong-Ja Im, Sang-Eun Yoon, et al.
Annals of Laboratory Medicine|September 30, 2024
Feasibility of Circulating Tumor DNA Detection in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement in Large B-Cell LymphomaSeok Jin Kim, Jin Ju Kim, Mi Ri Park, et al.
Cancer Research and Treatment|July 2, 2026
Clinico-Pathologic Features of Adult Erdheim-Chester Disease in South Korea: A Multicenter Retrospective Study (KCSG LY22-15)Ji Yun Lee, Heounjeong Go, Myung-Won Lee, et al.
Annals of Hematology|July 29, 2024
Long-term survival outcomes of 'watch and wait' in patients with bronchus-associated lymphoid tissue lymphoma: a multicenter real-world data analysis in KoreaKunye Kwak, Kwai Han Yoo, Yoon Seok Choi, et al.
Annals of Laboratory Medicine|April 26, 2022
Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple MyelomaHyun-Young Kim, In Young Yoo, Dae Jin Lim, et al.
Journal of Cancer|June 18, 2019
The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal CancerSang Eun Yoon, Su Jin Lee, Jeeyun Lee, et al.
Oncotargets and Therapy|January 15, 2019
The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practiceSang Eun Yoon, Su Jin Lee, Jeeyun Lee, et al.
Cancer Research and Treatment|December 27, 2024
Real-World Effectiveness and Safety of Intravenous Daratumumab in Patients with Multiple Myeloma: A Multicenter, Observational Study from KoreaYoungil Koh, Sung-Soo Yoon, Kihyun Kim, et al.
Cancer Research and Treatment|November 12, 2025
Chemotherapy-Free Salvage Therapy with Rituximab, Lenalidomide, and Poseltinib in Relapsed or Refractory Primary Central Nervous System Lymphoma: A Multi-Center, Phase II StudyDong Hyun Kim, Sanyeowool An, Hongyul Ahn, et al.
Pageof 14